News

Long-lasting HIV prevention shot headed toward approval
FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
By Deena Beasley (Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered ...
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
How 'The Handmaid's Tale' ends after 6 years in Gilead: Does June live?
Spoiler alert! Here's how Hulu's "The Handmaid's Tale" ends after six long seasons of June (Elisabeth Moss) in Gilead.
Gilead Sciences' Best Days May Be Ahead - Here's Why
Gilead Sciences is well-positioned to continue to strengthen its position as a leader in the HIV therapy market. Learn more ...
Soap Central15h
How every character’s story ends in The Handmaid’s Tale finale
In May 2025, The Handmaid’s Tale concluded its six-season run on television. The final episode closed the stories of several main characters who lived under the rule of Gilead, a strict regime that ...
pharmaphorum6d
ASCO 25: Gilead eyes first-line use of Trodelvy in TNBC
Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative ...
Gilead Commits to HIV Prevention Rollout for Low-Income Countries Despite Funding Uncertainty
(Reuters) -Gilead Sciences says it still plans to supply its twice-yearly injection for preventing HIV infection in ...
“The Testaments”: Everything to Know About “The” “Handmaid's Tale” Sequel Series (and the Different Side of Gilead It Will Depict)
The Emmy-winning series 'The Handmaid's Tale' ended its six-season run on May 27, but a sequel project is in the works ...